JNJ Leads Defensive Charge as Oil Prices Rise

Johnson & Johnson stock has seen renewed interest from investors as defensive healthcare names outperform in a volatile market environment.

According to recent data, healthcare and consumer staples stocks acted as a safe haven in the previous Wall Street session, with Johnson & Johnson among the names that were bought as risk appetite faded and volatility increased on September 2, 2026.

The defensive rotation lifted healthcare names, including Johnson & Johnson, which rose about 2 percent in the latest trading session.

In contrast to the Dow Jones Industrial Average's 0.79 percent drop over the same period, Johnson & Johnson shares outperformed, underscoring the stock's defensive characteristics and appeal for investors seeking relative stability when broader benchmarks are under pressure from higher yields and energy price volatility.